ATE292117T1 - Zusammensetzungen zur behandlung von hautkrankheiten - Google Patents

Zusammensetzungen zur behandlung von hautkrankheiten

Info

Publication number
ATE292117T1
ATE292117T1 AT00900030T AT00900030T ATE292117T1 AT E292117 T1 ATE292117 T1 AT E292117T1 AT 00900030 T AT00900030 T AT 00900030T AT 00900030 T AT00900030 T AT 00900030T AT E292117 T1 ATE292117 T1 AT E292117T1
Authority
AT
Austria
Prior art keywords
treatment
skin diseases
alkyl
compositions
formula
Prior art date
Application number
AT00900030T
Other languages
English (en)
Inventor
Jerzy Gebicki
Anna Sysa-Jedrzejowska
Jan Adamus
Original Assignee
Technical University Of Lodz
Jerzy Gebicki
Anna Sysa-Jedrzejowska
Jan Adamus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technical University Of Lodz, Jerzy Gebicki, Anna Sysa-Jedrzejowska, Jan Adamus filed Critical Technical University Of Lodz
Application granted granted Critical
Publication of ATE292117T1 publication Critical patent/ATE292117T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00900030T 1999-01-07 2000-01-07 Zusammensetzungen zur behandlung von hautkrankheiten ATE292117T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL330768A PL190755B1 (pl) 1999-01-07 1999-01-07 Preparat do leczenia i profilaktyki chorób skóry
PCT/IB2000/000019 WO2000040559A1 (en) 1999-01-07 2000-01-07 Compositions for the treatment of skin diseases

Publications (1)

Publication Number Publication Date
ATE292117T1 true ATE292117T1 (de) 2005-04-15

Family

ID=20073560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00900030T ATE292117T1 (de) 1999-01-07 2000-01-07 Zusammensetzungen zur behandlung von hautkrankheiten

Country Status (12)

Country Link
EP (1) EP1147086B9 (de)
AT (1) ATE292117T1 (de)
AU (1) AU1792700A (de)
CZ (1) CZ299662B6 (de)
DE (1) DE60019086T2 (de)
ES (1) ES2238985T3 (de)
HU (1) HU225475B1 (de)
PL (2) PL190755B1 (de)
RU (1) RU2199319C1 (de)
SK (1) SK285869B6 (de)
UA (1) UA73491C2 (de)
WO (1) WO2000040559A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ303214B6 (cs) * 2001-03-21 2012-05-30 Torrent Pharmaceuticals Ltd Pyridiniová sloucenina, zpusob její výroby, její použití, farmaceutický prostredek ji obsahující, zpusob jeho výroby a jeho použití
SE0102380D0 (sv) * 2001-07-02 2001-07-02 Macronova Ab Kräm för behandling av åldersförändringar i huden hos människa
RU2336867C2 (ru) * 2003-05-30 2008-10-27 ПАОЛИ АМБРОЗИ Джанфранко ДЕ Композиция для дермального применения, обладающая фотозащитным и антиэритемным действием, содержащая солнечный фильтр и диметилсульфон
RU2266538C2 (ru) * 2003-08-27 2005-12-20 Ванчакова Нина Павловна Способ идентификации противозудного эффекта антидепрессанта
PL364348A1 (en) 2004-01-12 2005-07-25 PHARMENA Sp.z o.o. Application of quaternary pyridine salts as vessel protection agent
DE102004013798A1 (de) * 2004-03-20 2005-10-06 Wella Aktiengesellschaft Verwendung von Mitteln zur kosmetischen Behandlung von Keratin enthaltenden Material
WO2007074406A2 (en) 2005-07-11 2007-07-05 Pharmena North America Inc. Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative
ATE438625T1 (de) * 2005-12-09 2009-08-15 Cerecon Ag Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel
DK2026651T3 (da) * 2006-03-08 2013-07-08 Cortria Corp Kombinationsterapi med ikke-selektive COX-inhibitorer til forebyggelse af COX-relaterede maveskader
US20080112968A1 (en) * 2006-10-11 2008-05-15 Dermena Nicotinamide compositions for treatment of skin diseases and disorders
CA2700585A1 (en) * 2006-10-18 2008-08-14 Dermena North America, Inc. Food extracts for treatment of lipoprotein abnormalities and skin diseases and skin disorders
US20100240621A1 (en) * 2007-09-10 2010-09-23 Glenmark Pharmaceuticals Ltd. Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
PL2211858T3 (pl) 2007-10-12 2015-06-30 Politechnika Lodzka Zastosowanie czwartorzędowych soli pirydyniowych do hamowania przerzutów nowotworowych
TWI432188B (zh) * 2008-12-19 2014-04-01 Merz Pharma Gmbh & Co Kgaa 供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類
WO2018015862A1 (en) 2016-07-18 2018-01-25 Pharmena S.A. 1-methylnicotinamide salts for use in raising the blood levels of adiponectin
JP7608422B2 (ja) 2019-07-12 2025-01-06 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ 生体エネルギー組み合わせ及びそれの使用方法
WO2021205341A1 (en) 2020-04-07 2021-10-14 Pharmena S.A. 1-methylnicotinamide for the prevention/treatment of inflammatory airway diseases
PL246761B1 (pl) * 2023-05-10 2025-03-03 Politechnika Poznanska Sposób otrzymywania czwartorzędowych soli amoniowych z kationem 3-karbamoilo-1-alkilopirydyniowym i anionem salicylanowym
PL248942B1 (pl) * 2024-01-31 2026-02-16 Politechnika Poznanska Czwartorzędowe sole amoniowe zawierające anion 2-furanokarboksylanowy i kation będący alkilową pochodną nikotynamidu, sposób ich otrzymywania i zastosowanie jako środki myjąco-dezynfekujące

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3823076A (en) * 1972-05-23 1974-07-09 Du Pont Zinc electroplating additive
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4578394A (en) * 1984-12-10 1986-03-25 Hoechst-Roussel Pharmaceuticals Incorporated Cholinergic function increasing 3-[N-(pyridyl) carbamoyl]-1,4-dihydropyridines
DE3603601C3 (de) * 1986-02-06 1999-12-23 Jutta Mai Verwendung eines Bockshornkleesamenextraktes
US4786647A (en) * 1986-06-30 1988-11-22 University Of Florida Method for eliciting anxiolysis
ZA892928B (en) * 1988-04-25 1991-01-30 Pro Neuron Inc Pharmaceutical compositions containing deoxyribonucleosides for wound healing
US5372911A (en) * 1991-06-13 1994-12-13 Dainippon Ink And Chemicals, Inc. Process of forming super high-contrast negative images and silver halide photographic material and developer being used therefor
US6238678B1 (en) * 1995-11-06 2001-05-29 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
RU2085187C1 (ru) * 1995-11-22 1997-07-27 Исследовательская корпорация МДТ Гель для ухода за кожей и лечения ее заболеваний и композиция для его получения
US6028111A (en) * 1996-03-08 2000-02-22 Oxigene, Inc. Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
US20040102358A1 (en) * 1997-05-19 2004-05-27 Scivoletto Rosemarie Composition for treating skin conditions
EP1063994A1 (de) * 1998-03-16 2001-01-03 The Procter & Gamble Company Behandlung der hautreizung

Also Published As

Publication number Publication date
ES2238985T3 (es) 2005-09-16
DE60019086D1 (de) 2005-05-04
SK9512001A3 (en) 2001-12-03
RU2001121650A (ru) 2004-02-27
UA73491C2 (uk) 2005-08-15
SK285869B6 (sk) 2007-10-04
RU2199319C1 (ru) 2003-02-27
HUP0104963A3 (en) 2002-11-28
HU225475B1 (en) 2006-12-28
EP1147086A1 (de) 2001-10-24
PL190755B1 (pl) 2006-01-31
PL330768A1 (en) 2000-07-17
DE60019086T2 (de) 2006-02-02
CZ299662B6 (cs) 2008-10-08
WO2000040559A1 (en) 2000-07-13
CZ20012450A3 (cs) 2002-10-16
PL396696A1 (pl) 2012-01-16
EP1147086B1 (de) 2005-03-30
ES2238985T9 (es) 2011-03-24
HUP0104963A2 (hu) 2002-04-29
EP1147086B9 (de) 2010-09-22
AU1792700A (en) 2000-07-24

Similar Documents

Publication Publication Date Title
DE60019086D1 (de) Zusammensetzungen zur behandlung von hautkrankheiten
SE9604786D0 (sv) New compounds
TR200102072T2 (tr) İltihap karşıtı maddeler olarak aromatik çok döngülü bileşimler
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
TR200001840T2 (tr) Arile bağlı azopolisiklik bileşikler
ATE119520T1 (de) Derivate von hydroxaminsäure und von n- hydroxyharnstoff sowie ihre verwendung.
DE60045508D1 (de) Dalda-analoge und ihre verwendung
SE0100569D0 (sv) New compounds
BG106155A (en) Novel derivatives and analogues of galanthamin
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
ATE322878T1 (de) Biotin enthaltende galenische formulierung
DK284386A (da) Farmaceutisk praeparat mod hudlidelser
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE69530988D1 (de) Benzimidazolderivate mit dopaminerger wirkung
DE69819539D1 (de) Antithrombotische mittel
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
DE60139409D1 (de) Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen
KR960010003A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
DE69828522D1 (de) Antithrombotische mittel
HRP20040421B1 (hr) INHIBICIJA VIRUSA n-DOKOZANOLOM
DE60119514D1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1147086

Country of ref document: EP

EEIH Change in the person of patent owner